ArticleScientific reports2025
Prediction of contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma based on radiomics.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinicopathological Predictors of Contralateral Central Lymph Node Metastasis in Patients With Unifocal Papillary Thyroid Carcinoma.Head & neck · 2026Article
- CT-based renal and body-composition radiomics model to improve the detection ability of diabetic kidney disease in patients with type 2 diabetes mellitus.Frontiers in endocrinology · 2026Article
- False-positive cervical lymph nodes on FAPI PET/CT after neoadjuvant chemotherapy for breast cancer: a case report.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This study aims to examine the determinants of contralateral central lymph node metastasis in cases of unilateral papillary thyroid carcinoma, utilizing clinical pathological parameters and ultrasound radiomics. The goal is to develop an optimal predictive model that can inform clinical decisions regarding contralateral central lymph node dissection in patients with unilateral papillary thyroid cancer. A cohort of 329 patients diagnosed with unilateral papillary thyroid carcinoma, all of whom underwent bilateral thyroidectomy and bilateral central lymph node resection, were analyzed. Clinical data were systematically collected, and a logistic regression analysis model was constructed. The patient cohort was randomly divided into a training set and a validation set in an 8:2 ratio. Radiomic features were extracted from ultrasound images using the open-source software pyradiomic, leading to the establishment of three models: a clinical model, a radiomics model, and a combined clinical and radiomics model. The area under the curve (AUC) for the logistic regression model was found to be 0.843. In the training set, the AUCs for the clinical model, the radiomics feature model, and the combined clinical and radiomics feature model developed using random forest were 0.7645, 0.9633, and 0.9726, respectively. In the validation set, the AUCs for the clinical model, the radiomics feature model, and the combined clinical and radiomics feature model developed using random forest were 0.7358, 0.9558, and 0.9694, respectively. The combined model incorporated four clinical features and seven radiomic features, specifically: age, tumor size, presence of microcalcification, presence of ipsilateral central lymph node metastasis, elongation, perimeter, sphericity, maximum probability, large dependence emphasis, first-order range, and cluster shade. The combined clinical and radiomics model developed in this research demonstrates strong predictive diagnostic efficacy. The establishment of this innovative model is anticipated to provide a robust theoretical framework for clinicians considering preventive bilateral central lymph node dissection in patients with unilateral papillary thyroid carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.